会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明公开
    • Stereofluoroscopic apparatus
    • 立体荧光
    • EP0063252A1
    • 1982-10-27
    • EP82102418.9
    • 1982-03-23
    • Nishiyama, ShojiKABUSHIKI KAISHA TOSHIBA
    • Shoji, NishiyamaSenzo, FujiiKatsutoshi, Ito
    • H04N5/32H04N9/54
    • H04N5/32
    • Disclosed is a sterofluoroscopic apparatus having a bifocal point X-ray tube (106) which radiates X-rays from different directions through a subject to form two X-ray images, and two projecting type CRTs (118-1, 118-2) which receive respective image signals corresponding to the two X-ray images and which project the images on a transmissive screen (122) of double-lenticulated lens sheet structure. The apparatus further has a lenticular lens sheet (136 - 1) on a flat surface of which is formed a photosensitive member (136-2), and a movable reflecting mirror (138) which, when set in a reflecting position, reflects the images from the CRTs (118-1, 118-2) to guide the images from the CRTs (118-1, 118-2) on the lenticular lens sheet (136-1).
    • 公开了一种具有双焦点X射线管(106)的立体感X射线管(106),其通过对象从不同方向辐射X射线以形成两个X射线图像,以及两个投影型CRT(118-1,118-2),其中 接收与两个X射线图像相对应的各个图像信号,并且将图像投影在双倍透镜式透镜片结构的透射屏幕(122)上。 该装置还在其平坦表面上形成一个双凸透镜片(136-1),形成一个光敏元件(136-2)和一个可移动的反射镜(138),当设置在反射位置时,反射镜 从CRT(118-1,118-2)引导来自双凸透镜片(136-1)上的CRT(118-1,118-2)的图像。
    • 9. 发明申请
    • TRITERPENE DERIVATIVES AND REMEDY FOR LIVER DISEASES
    • TRAILRPENE DIVIVATIVES AND REMEDY FOR LIVER DISEASES
    • WO1997003088A1
    • 1997-01-30
    • PCT/JP1996001891
    • 1996-07-08
    • MEIJI SEIKA KABUSHIKI KAISHASASAKI, KazueMINOWA, NobutoNISHIYAMA, ShojiKUZUHARA, Hiroyuki
    • MEIJI SEIKA KABUSHIKI KAISHA
    • C07J63/00
    • C07J63/008C07J71/0005
    • A remedy for liver diseases which comprises a triterpene derivative represented by following general formula (I) or a pharmaceutically acceptable salt thereof wherein R represents hydroxy, alkoxy, alkylcarbonyloxy or aralkyloxy; R represents alkyl, -CH2O (wherein R represents hydrogen, alkyl, aralkyl or akylcarbonyl), formyl, -COOR (wherein R represents hydrogen or alkyl) or -CH2N(R )R , or R and R are bonded to each other to form -O-CR (R )-OCH2- (wherein R and R are the same or different and each represents hydrogen, alkyl or aryl); R and R are the same or different and each represents hydrogen, hydroxy, alkyl, hydroxyalkyl, formyl, -COOR (wherein R represents hydrogen or alkyl) or -OR (wherein R represents alkyl, aralkyl, C1-6 alkylcarbonyl, arylcarbonyl, alkenyl, alkenylcarbonyl or optionally substituted arylalkenylcarbonyl, or R and R together form methylene; and - - - represents a single or double bond, provided that when - - - is a double bond, then R is not present.
    • 一种肝病的治疗方法,其包含由以下通式(I)表示的三萜衍生物或其药学上可接受的盐,其中R 1表示羟基,烷氧基,烷基羰氧基或芳烷氧基; R 2表示烷基,-CH 2 O(其中R 5表示氢,烷基,芳烷基或烷基羰基),甲酰基,-COOR 6(其中R 6表示氢或烷基)或-CH 2 N(R 7 )R 8或R 1和R 2彼此键合以形成-O-CR 9(R 10)-O 2 2-(其中R 9和R 10 >相同或不同,各自表示氢,烷基或芳基); R 3和R 4相同或不同,各自表示氢,羟基,烷基,羟烷基,甲酰基,-COOR 11(其中R 11表示氢或烷基)或-OR 12( 其中R 12表示烷基,芳烷基,C 1-6烷基羰基,芳基羰基,烯基,烯基羰基或任选取代的芳基烯基羰基,或R 3和R 4一起形成亚甲基;和 - 表示单键或双键,条件是当< - - - - 双键时,则不存在R 4。